Navigation Links
Amgen to Present at the Thomas Weisel Healthcare Conference
Date:9/8/2009

THOUSAND OAKS, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will participate in the Thomas Weisel Healthcare Conference on Friday, Sept. 11, 2009, at the Four Seasons in Boston, Mass. beginning at 8:35 a.m. Eastern Time. Roy Baynes, M.D. Ph.D., vice president of Global Development for Amgen, will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    Arvind Sood, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amgen to Present at the Baird Healthcare Conference
2. Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs
3. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
4. Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
5. Amgen Announces Webcast of 2009 Second Quarter Financial Results
6. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
7. Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
8. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
9. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
10. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
11. Amgen to Present at the Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... Floundering on New ... Month and the perfect time for a reset. The U.S. Apple Association agrees and ... combat many of the factors that contribute to heart disease. , The U.S. Apple ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone wants less ... best drug option for each patient. Dentists have several general anesthesia alternatives and finding ... Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find out which ...
(Date:1/17/2017)... ... 17, 2017 , ... In the crowded Ath-leisure market, it ... company for several differences from other mainstream brands. , Firstly, in the ... called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . It allows them to have a ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with medical ... moments that help everyone endure and pass through tough times, Dr. Bernie Siegel ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... SunView Software’s ... Award for Innovation of the Year. , Each year, Pink Elephant recognizes ... an innovative approach to address a specific business problem or opportunity. The award highlights ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... , January 18, 2017 ... the company plans to publish an online presentation ... Company,s preliminary sales forecast for 2017. Management reports ... trialing ninety-day record sales performance from its existing ... recently announced entry into the Cannabis sector ...
(Date:1/18/2017)... Regulatory Authority Chinese Food and Drug Administration CSL ... Flanders Institute Food and Drug Administration FORT ... Glaxo Smith Klein GlaxoWellcome Global ... Japan Immune Targeting Systems Indian Association ... oxford Johnson & Johnson Krka Pharmaceuticals ...
Breaking Medicine Technology: